Journal of Clinical Trials 2018
Top Research Directions
The 3 research directions with Journal of Clinical Trials 2018 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.
| # | Direction | Papers | Share |
|---|---|---|---|
| 1 | Reprogramming Immune Cells for Targeted Cancer Therapy | 1 | 100.0% |
| 2 | Resolving Intratumoral Heterogeneity for Precision Cancer Stratification | 1 | 100.0% |
| 3 | Standardized Frameworks for Tumor Response Assessment | 1 | 100.0% |
Download all directions as CSV
About this data
Papers. Journal of Clinical Trials 2018 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.
Data. Counts come from Lacuna’s data build of 2026-11-21 and change as papers are added. Tables as CSV: directions. Cite as: Lacuna, “Journal of Clinical Trials 2018”, https://lacuna.tiptreesystems.com/venue/journal-of-clinical-trials/2018.
Impactful Papers
Papers from Journal of Clinical Trials 2018 that shaped research clusters.
Foundational
Papers
| Title |
|---|
| Personalized Chimeric Antigen Receptor T- Cell Immunotherapy for Patients with Recurrent Malignant Gliomas |